Claire MacKoul

Claire V. MacKoul is an associate director in BRG’s Health Analytics practice, based out of BRG’s Boston office.

She provides consulting services to life sciences companies with a specific focus on new product development, drug pricing and reimbursement, and product liability. She has advised pharmaceutical and healthcare companies and provided expert support through quantitative and qualitative analyses for litigation matters and investigations.

Ms. MacKoul has led the day-to-day operations of BRG teams providing complex sales and claims analyses, potential exposure analyses, electronic data collection and discovery services, and expert opinions on industry standards and damages. She specializes in applying industry knowledge and litigation experience to analyze documents and data efficiently and effectively and present findings in easily digestible, informative work product.

Ms. MacKoul has consulted both pharmaceutical manufacturers and pharmacy benefit managers (PBMs) on drug pricing and reimbursement matters, particularly related to generic pharmaceuticals. She has conducted exposure modeling and litigation support for clients involved in the generic drug pricing antitrust litigation and the maximum allowable cost (MAC) pricing litigation.

Ms. MacKoul also has been extensively involved in consulting for pharmaceutical manufacturers and PBMs involved in opioid litigation—both advising companies on potential exposure and assisting with expert opinions on industry standards and damages analyses.